12th Edition of International Conference on Neurology and Brain Disorders
October 20-22, 2025
Translational Neurology
Translational neurology bridges the gap between laboratory research and clinical application, accelerating advancements in neurological care. By transforming fundamental discoveries into practical treatments, this field addresses unmet medical needs in conditions such as Parkinson’s disease, Alzheimer’s, and spinal cord injuries. Translational Neurology emphasizes the importance of preclinical studies in developing targeted therapies, ensuring their efficacy and safety before clinical trials. Emerging technologies like gene editing and stem cell therapy are pivotal in shaping innovative approaches for neurological repair and regeneration. Collaborative efforts between researchers and clinicians foster real-world applications, ultimately enhancing patient outcomes and paving the way for groundbreaking interventions.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Joe Sam Robinson
Mercer University, United States
Robert B Slocum
University of Kentucky HealthCare, United States
Thomas J Webster
Interstellar Therapeutics, United States
Roger H Coletti
Interventional Health, PA, United States
Stephen Grossberg
Boston University, United States
George Diaz
Memorial Healthcare Systems, United StatesSubmit your abstract Today
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : TBI updates in 2025
Jonathan Eskenazi, Cedars Sinai / UCLA, United States
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Non-pharmacological strategies to counteract oxaliplatin toxicity: Protective effects of vagal nerve stimulation and resistance training on neuropathy, motor dysfunction, and muscle atrophy
Ricardo Aparecido Baptista Nucci, Hospital Sirio-Libanes, Brazil
Title : Synapticare: Integrating sleep data and tau biomarkers to assess depression severity
Medha Menon, John Foster Dulles HS, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States